Literature DB >> 7361118

Faster cholinergic REM sleep induction in euthymic patients with primary affective illness.

N Sitaram, J I Nurnberger, E S Gershon, J C Gillin.   

Abstract

Arecoline, a cholinergic muscarinic receptor agonist, induced rapid eye movement sleep significantly more rapidly in patients with primary affective illness in remission than in normal control subjects matched for age and sex. These results, and others, suggest that patients with primary affective illness may have a supersensitive cholinergic system both when they are ill and when their symptoms are in clinical remission.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361118     DOI: 10.1126/science.7361118

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

Review 1.  Current perspectives on the genetics of unipolar depression.

Authors:  S O Moldin; T Reich; J P Rice
Journal:  Behav Genet       Date:  1991-05       Impact factor: 2.805

2.  Psychiatry-epitomes of progress: cholinergic hypersensitivity in patients with affective disorders.

Authors:  D S Janowsky
Journal:  West J Med       Date:  1981-02

3.  Loose ends of psychiatric research.

Authors:  Martin Alda; Tomas Hajek
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

4.  Muscarinic receptors in brain from four strains of inbred mice.

Authors:  J Baumgold
Journal:  Neurochem Res       Date:  1987-12       Impact factor: 3.996

Review 5.  Acetylcholine and affective disorder.

Authors:  S S Leong; W A Brown
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 6.  Genetic and pharmacological models of cholinergic supersensitivity and affective disorders.

Authors:  D H Overstreet; R W Russell; A D Crocker; J C Gillin; D S Janowsky
Journal:  Experientia       Date:  1988-06-15

7.  Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.

Authors:  J Fritze; M Lanczik; E Sofic; M Struck; P Riederer
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

8.  A brief history of hypocretin/orexin and narcolepsy.

Authors:  J M Siegel; R Moore; T Thannickal; R Nienhuis
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

Review 9.  Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.

Authors:  Stephanie C Dulawa; David S Janowsky
Journal:  Mol Psychiatry       Date:  2018-08-17       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.